| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-10 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-08 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |